Prevalence of claudin 18.2 in gastric cancer patients from India
There is no data from India regarding the prevalence of Claudin 18.2 (CLDN18.2) in patients with gastric adenocarcinomas (GC). Records of treatment-naive, histologically confirmed gastric cancer (GC) diagnosed between January 2018 and October 2023 were retrieved from a prospectively maintained database at th...